PE Tech Report


Like this article?

Sign up to our free newsletter

EQT to sell infection prevention specialist Schülke

EQT’s EQT VIII fund is to sell Schülke, a provider of infection prevention and treatment solutions for the healthcare industry, to a consortium led by ATHOS, a Munich-based single family office, along with other co-investors such as Bitburger Holding.

Schülke has an almost 135-year track record of developing holistic and infection prevention and treatment solutions. It supplies hospitals and other healthcare institutions with disinfectants and antisepsis products, and also sells to the pharmacy and direct patient care channels, as well as the global life science industry.

Schülke is headquartered in Norderstedt, Germany, employs approximately 1,200 people, and generates sales in more than 80 countries with market leading positions in Central and Eastern Europe, Australia and Brazil.

Since Schülke was acquired by EQT in July 2020, the company has delivered double-digit annual revenue growth and almost doubled EBITDA in its core healthcare business.

The transaction, which is subject to customary regulatory approvals, is expected to close in Q4 2023.

EQT Private Equity was advised by Bank of America, Freshfields Bruckhaus Deringer, Deloitte and Bain & Company.

Like this article? Sign up to our free newsletter